Abstract TP065: Patient, Surrogate, and Provider Perspectives in Cerebrovascular Reperfusion Therapy

Introduction: Cerebrovascular reperfusion therapies are essential in treating ischemic stroke, but the urgency of decision-making often requires expedited consent, potentially limiting patient or surrogate understanding of risks, benefits, and expectations. Evaluating consent adequacy may help improve comprehension and shared decision-making during time-sensitive interventions. Methods: This single-institution cross-sectional study examined the consent process for reperfusion therapy from the perspectives of patients, surrogates, and clinicians. 34 patients (or surrogates) undergoing acute thrombolysis with tenecteplase (TNK) and 45 patients (or surrogates) undergoing elective neuroendovascular procedure (cerebral aneurysm embolization or digital subtraction angiography), completed a validated consent adequacy survey within five days of treatment (June 2024–June 2025). Survey domains included therapy received, consent type, communication adequacy, satisfaction, and post-procedure assessments. Results: All patients felt informed regarding major risks. However, elective neuroendovascular procedure participants reported significantly greater understanding of minor risks (93.3% vs. 55.9%, p=0.001), future management (88.9% vs. 64.7%, p